SunTrust analyst Youssef Squali raised the firm's price target on Cardlytics to $77 from $52 and keeps a Buy rating on the shares. The analyst notes the company's "strong" Q4 results while attributing the soft Q1 guidance to the impact of coronavirus and the slower WF monetization ramp. Squali adds that a growing sales team and greater advertiser density should allow Cardlytics to sustain monetization/revenue growth at 20%-30% "for years to come" and attributes the sharp post-earnings sell-off to the 400% trailing-12-month run-up in the stock relative to the 7.5% advance for S&P500.